M1 CRPC: PARP Inhibitors, Microsatellite Instability and Precision Medicine

M1 CRPC: PARP Inhibitors, Microsatellite Instability and Precision Medicine: Kristen R. Scarpato, MD, MPH
CME AVAILABLE: auau.auanet.or...
ACKNOWLEDGEMENTS
This educational activity is supported by independent educational grants from:
Astellas
AstraZeneca
Bayer HealthCare Pharmaceuticals Inc.
Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC
Merck & Co., Inc.
Novartis Pharmaceuticals Corporation
Pfizer, Inc.